Skip to content 
As healthcare systems worldwide embrace digital transformation, the integration of artificial intelligence is reshaping how diseases are diagnosed and managed. At the forefront of this evolution is Transmural Biotech S.L., a Barcelona-based pioneer dedicated to advancing clinical practice through cutting-edge image analysis and AI-powered diagnostics.
Founded in 2009 as a spin-off from the Hospital Clinic of Barcelona and the University of Barcelona, Transmural Biotech was born from the collaboration of medical and engineering experts. Their shared vision: to enhance patient care by leveraging technology to deliver faster, more accurate, and non-invasive diagnostic solutions.
AI-Powered Diagnostics for Modern Medicine
Transmural Biotech specializes in developing advanced algorithms capable of analyzing medical images to detect a wide range of diseases. By collaborating with healthcare institutions, the company has built powerful tools that enable personalized, efficient, and cost-effective diagnostics.
Its flagship solutions include:
- quantusSKIN for dermatology
- quantusGL for ophthalmology
- quantusFLM for maternal-fetal health
In addition, the company is actively involved in research across critical areas such as breast cancer, osteoporosis, and diabetic retinopathy—demonstrating its commitment to addressing some of the most pressing healthcare challenges.
Innovation Backed by Data and Precision
A defining strength of Transmural Biotech lies in its ability to combine large-scale medical image databases with artificial neural networks. By organizing and linking imaging data with clinical information—while maintaining strict compliance with data protection standards—the company has developed systems capable of delivering diagnostic insights with accuracy comparable to human experts, but up to 25 times faster.
These solutions are fully non-invasive, accessible remotely, and designed to improve clinical decision-making while reducing the burden on healthcare professionals.
A Vision for Predictive and Preventive Healthcare
Transmural Biotech’s mission extends beyond diagnosis—it aims to transform clinical practice through predictive analytics. By identifying patterns and risks early, its technologies enable healthcare providers to intervene sooner, improving patient outcomes and reducing long-term costs.
The company envisions a future where medicine is:
- Predictive – anticipating diseases before they fully develop
- Personalized – tailored to individual patient needs
- Preventive – reducing the likelihood of severe conditions
- Efficient – saving time and resources for healthcare systems
Driving Innovation Through Collaboration
With support from Grupo Asisa, one of Spain’s largest healthcare groups, Transmural Biotech has expanded its global reach across Europe, Latin America, and Asia. Its collaborations with leading medical institutions continue to fuel innovation and ensure real-world applicability of its solutions.
The company’s multidisciplinary team—combining expertise in medicine, engineering, and data science—plays a crucial role in delivering solutions that are both technically advanced and clinically relevant.
Spotlight on Breakthrough Innovation
One of the company’s most significant recent developments is quantusMM, a non-invasive diagnostic tool for early detection of breast pathologies. Developed in collaboration with the Basque Health Service and the Biodonostia Institute, this solution uses mammography to identify malignant nodules and microcalcifications—supporting early detection of breast cancer.
In addition to product innovation, Transmural Biotech is expanding into education, offering training programs in AI concepts such as machine learning, deep learning, and computer vision—helping to build the next generation of healthcare innovators.
Leadership with Vision
Under the leadership of Miguel Ángel Lorente and David Fernández, the company continues to push the boundaries of digital medicine. Their combined expertise in healthcare strategy and advanced technology has been instrumental in positioning Transmural Biotech as a leader in AI-driven diagnostics.
Shaping the Future of Healthcare
Artificial intelligence is no longer a distant concept—it is actively transforming how healthcare is delivered. Transmural Biotech stands at the center of this transformation, proving that technology can enhance accuracy, improve efficiency, and ultimately save lives.
With a steadfast commitment to research, ethical innovation, and patient-centric solutions, Transmural Biotech is not just advancing science—it is redefining the future of global healthcare.
